Longboard Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatme…

Biotechnology
US, La Jolla [HQ]
Supply · Problems · Premarket · Compliance

Supply Analysis

End of LBPH's Analysis
CIK: 1832168 CUSIP: 54300N103 ISIN: US54300N1037 LEI: - UEI: -
Secondary Listings
LBPH has no secondary listings inside our databases.